CAPN1 and breast carcinoma: Indeed, translational studies in a large cohort of triple-negative and basal-like breast cancer patients found that calpain-1 was not associated with relapse-free survival and identified calpain-2 as the isoform associated with adverse outcomes (Storr et al., 2012).